Business
Asston Pharmaceuticals Limited, a Pharmaceutical and Nutraceutical Company, opens its IPO on 9th July 2025.
[ad_1]
Mumbai (Maharashtra) [India], July 7: Asston Pharmaceuticals Limited, a pharmaceutical and nutraceutical company headquartered in Navi Mumbai, Maharashtra, has announced the opening of its IPO on July 09, 2025, with a proposed issue size of ₹27.56 Crores. The shares are proposed to be listed on the SME Platform of BSE Limited (BSE SME).
The issue is being made through a 100% book-building process in accordance with SEBI regulations.
Equity Share Allocation
- QIB Anchor Portion – Up to 6,35,000 Equity Shares
- Qualified Institutional…
[ad_2]
Source link
Continue Reading
You must be logged in to post a comment Login